Adrenocortical Carcinoma clinical trials at UCSD
1 research study open to new patients
-
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
open to eligible people ages 18 years and up
This research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies. -The names of the study drugs involved in this study are: - Nivolumab - Ipilimumab
La Jolla, California and other locations
Last updated: